LONDON, May 5, 2011 /PRNewswire/ -- At the 2011 European Society for Therapeutic Radiology and Oncology (ESTRO) exhibition, 8-12 May at the ExCel Centre in London, Elekta will demonstrate advanced solutions that provide clinicians with the tools to save and improve lives of cancer patients worldwide. This includes Elekta’s new RFID system, Identify*, which is designed to increase staff confidence in the integrity of patient identification and set up.
Identify harnesses precision radiofrequency identification technology and will ensure the right patient is being treated at the right location and with the correct set up and equipment. Identify will feature complete integration with Elekta’s MOSAIQ® Oncology Information System, enabling patient queuing, selection of patient details in monitoring of set-up position, optimizing workflow and enhancing safety. Identify will be a scalable solution from the treatment room to the entire department allowing centers to grow as needs change.
“Elekta has spent decades continually improving our radiation oncology solution, based significantly on customer input and collaboration,” says Olof Sanden, Executive Vice President, Europe and AFLAME. “The result has been products that combine increasing technological capabilities with easier, more confident use. The addition of Identify to our portfolio will address the desire of our customers to confidently use the most advanced therapies while also ensuring that these treatments are as safe as possible.”
Other meeting highlights
Throughout the five major solution areas at Elekta booth #020, the company will demonstrate how its digital platforms offer robust upgrade paths to accommodate a wide range of clinical requirements. The solution areas are:
- Secure Workflow personalized efficiency
- Stereotaxy premium solutions for the most challenging cases
- Delivery clinically focused, digitally controlled
- Imaging inspiring clinical confidence
- Quality Assurance completing the picture
In addition, Elekta will host a lunch symposium titled Throughput with Confidence on Monday, 9 May from 13:00 - 14:30 at the Capital Suites, Level 3 in rooms 7-9. An interactive forum, the symposium will feature presentations by notable experts in the field of radiation oncology:
- Prof. Frank Lohr, University Hospital, Mannheim, Germany: Efficient VMAT Planning and Delivery
- Ben J. Mijnheer, PhD, NKI/AvL, Amsterdam, Netherlands: Experiences from AvL with EPID-based In-Vivo Dosimetry
- PD Dr. Reinhart A. Sweeney, University Hospital, Wurzburg, Germany; Christian Hieronimi, Elekta: Identify - who, what, where and how. Now!
To learn more about Elekta’s innovations at ESTRO, visit www.elekta.com/experience.
*Identify is a works in progress and not available for sale or distribution in all markets.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
SOURCE Elekta
